250 related articles for article (PubMed ID: 12210443)
21. Estimates of long-term survival for newly diagnosed cancer patients: a projection approach.
Mariotto AB; Wesley MN; Cronin KA; Johnson KA; Feuer EJ
Cancer; 2006 May; 106(9):2039-50. PubMed ID: 16572414
[TBL] [Abstract][Full Text] [Related]
22. Localized pelvic neuroblastoma: excellent survival and low morbidity with tailored therapy--the 10-year experience of the French Society of Pediatric Oncology.
Leclair MD; Hartmann O; Heloury Y; Fourcade L; Laprie A; Mechinaud F; Munzer C; Rubie H
J Clin Oncol; 2004 May; 22(9):1689-95. PubMed ID: 15117991
[TBL] [Abstract][Full Text] [Related]
23. Long-term survival probabilities for childhood rhabdomyosarcoma. A population-based evaluation.
Punyko JA; Mertens AC; Baker KS; Ness KK; Robison LL; Gurney JG
Cancer; 2005 Apr; 103(7):1475-83. PubMed ID: 15712283
[TBL] [Abstract][Full Text] [Related]
24. Neuroblastoma: epidemiology and pattern of regression. Problems in interpreting results of mass screening.
Carlsen NL
Am J Pediatr Hematol Oncol; 1992 May; 14(2):103-10. PubMed ID: 1530115
[TBL] [Abstract][Full Text] [Related]
25. Neuroblastoma today.
Ferster A; Schots R; Maurus R; Otten J
Biomed Pharmacother; 1988; 42(4):247-55. PubMed ID: 3056532
[TBL] [Abstract][Full Text] [Related]
26. Neuroblastoma in adults: Incidence and survival analysis based on SEER data.
Esiashvili N; Goodman M; Ward K; Marcus RB; Johnstone PA
Pediatr Blood Cancer; 2007 Jul; 49(1):41-6. PubMed ID: 16628557
[TBL] [Abstract][Full Text] [Related]
27. Up-to-date estimates of cancer patient survival even with common latency in cancer registration.
Brenner H; Hakulinen T
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1727-32. PubMed ID: 16985036
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors in neuroblastoma.
Kajanti M; Holsti P
Ann Clin Res; 1986; 18(3):129-33. PubMed ID: 3740789
[TBL] [Abstract][Full Text] [Related]
29. [Improved survival in children with neuroblastoma].
Schrøder H; Wacher J; Larsson H; Rosthøj S; Rechnitzer C; Petersen BL; Carlsen NL
Ugeskr Laeger; 2010 Oct; 172(40):2761-5. PubMed ID: 20926047
[TBL] [Abstract][Full Text] [Related]
30. Trends in survival after childhood cancer in Slovenia between 1957 and 2007.
Perme MP; Jereb B
Pediatr Hematol Oncol; 2009 Jun; 26(4):240-51. PubMed ID: 19437326
[TBL] [Abstract][Full Text] [Related]
31. From cancer to transplantation: an evaluation of period analysis for calculating up-to-date long-term survival estimates.
Gondos A; Doehler B; Opelz G; Brenner H
Am J Epidemiol; 2010 Sep; 172(5):613-20. PubMed ID: 20650955
[TBL] [Abstract][Full Text] [Related]
32. Neuroblastoma in adolescents.
Gaspar N; Hartmann O; Munzer C; Bergeron C; Millot F; Cousin-Lafay L; Babin-Boilletot A; Blouin P; Pajot C; Coze C
Cancer; 2003 Jul; 98(2):349-55. PubMed ID: 12872356
[TBL] [Abstract][Full Text] [Related]
33. Trends in survival after childhood cancer in Europe, 1978-1997: report from the Automated Childhood Cancer Information System project (ACCIS).
Magnani C; Pastore G; Coebergh JW; Viscomi S; Spix C; Steliarova-Foucher E
Eur J Cancer; 2006 Sep; 42(13):1981-2005. PubMed ID: 16919766
[TBL] [Abstract][Full Text] [Related]
34. [Lorraine childhood cancer registry: incidence, survival 1983-1999].
Lacour B; Desandes E; Mallol N; Sommelet D
Arch Pediatr; 2005 Nov; 12(11):1577-86. PubMed ID: 16099145
[TBL] [Abstract][Full Text] [Related]
35. [Experiences with Langerhans' cell histiocytosis in children in Hungary].
Müller J; Koós R; Garami M; Hauser P; Borgulya G; Schuler D; Benyó G; Magyarosy E; Galántai I; Milei K; Török K; Bárdi E; Hunyadi K; Gábor K; Masáth P; Bodnár L; Kovács G
Magy Onkol; 2004; 48(4):289-95. PubMed ID: 15655573
[TBL] [Abstract][Full Text] [Related]
36. Providing more up-to-date estimates of patient survival: a comparison of standard survival analysis with period analysis using life-table methods and proportional hazards models.
Smith LK; Lambert PC; Botha JL; Jones DR
J Clin Epidemiol; 2004 Jan; 57(1):14-20. PubMed ID: 15019006
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcome and toxicities of intraoperative radiotherapy for high-risk neuroblastoma.
Gillis AM; Sutton E; Dewitt KD; Matthay KK; Weinberg V; Fisch BM; Chan A; Gooding C; Daldrup-Link H; Wara WM; Farmer DL; Harrison MR; Haas-Kogan D
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):858-64. PubMed ID: 17517478
[TBL] [Abstract][Full Text] [Related]
38. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
Pulte D; Gondos A; Brenner H
J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
[TBL] [Abstract][Full Text] [Related]
39. Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis.
Brenner H; Arndt V
J Clin Oncol; 2005 Jan; 23(3):441-7. PubMed ID: 15572727
[TBL] [Abstract][Full Text] [Related]
40. An alternative approach to monitoring cancer patient survival.
Brenner H; Gefeller O
Cancer; 1996 Nov; 78(9):2004-10. PubMed ID: 8909323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
